1-9 of 9
Burkhard Goke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modern Methods of Transcriptomic and Peptidomic Profiling of Enteroendocrine Cells Promise Progress for a Better Understanding of (Patho)physiology and New Therapies for Obesity and Diabetes

Burkhard Göke
Journal: Diabetes
Diabetes 2019;68(5):904–905
https://doi.org/10.2337/dbi18-0050
Published: 16 April 2019
View article titled, Modern Methods of Transcriptomic and Peptidomic Profiling of Enteroendocrine Cells Promise Progress for a Better Understanding of (Patho)physiology and New Therapies for Obesity and Diabetes
Open the PDF for Modern Methods of Transcriptomic and Peptidomic Profiling of Enteroendocrine Cells Promise Progress for a Better Understanding of (Patho)physiology and New Therapies for Obesity and Diabetes in another window
Journal Articles

Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade

Benedikt A. Aulinger, Anne Bedorf, Gabriele Kutscherauer, Jocelyn de Heer, Jens J. Holst, Burkhard Göke, Jörg Schirra
Journal: Diabetes
Diabetes 2014;63(3):1079–1092
https://doi.org/10.2337/db13-1455
Published: 13 February 2014
View article titled, Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
Open the PDF for Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade in another window
Includes: Supplementary data
Journal Articles

GLP-1—A Candidate Humoral Mediator for Glucose Control After Roux-en-Y Gastric Bypass

Jörg Schirra, Burkhard Göke
Journal: Diabetes
Diabetes 2014;63(2):387–389
https://doi.org/10.2337/db13-1660
Published: 16 January 2014
View article titled, GLP-1—A Candidate Humoral Mediator for Glucose Control After Roux-en-Y Gastric Bypass
Open the PDF for GLP-1—A Candidate Humoral Mediator for Glucose Control After Roux-en-Y Gastric Bypass in another window
Journal Articles

The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes

Hans Juergen Woerle, Lucianno Carneiro, Ayman Derani, Burkhard Göke, Jörg Schirra
Journal: Diabetes
Diabetes 2012;61(9):2349–2358
https://doi.org/10.2337/db11-1701
Published: 17 August 2012
View article titled, The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
Open the PDF for The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes in another window
Journal Articles

Changing Metabolic Signatures of Amino Acids and Lipids During the Prediabetic Period in a Pig Model With Impaired Incretin Function and Reduced β-Cell Mass

Simone Renner, Werner Römisch-Margl, Cornelia Prehn, Stefan Krebs, Jerzy Adamski, Burkhard Göke, Helmut Blum, Karsten Suhre, Adelbert A. Roscher, Eckhard Wolf
Journal: Diabetes
Diabetes 2012;61(8):2166–2175
https://doi.org/10.2337/db11-1133
Published: 17 July 2012
View article titled, Changing Metabolic Signatures of Amino Acids and Lipids During the Prediabetic Period in a Pig Model With Impaired Incretin Function and Reduced β-Cell Mass
Open the PDF for Changing Metabolic Signatures of Amino Acids and Lipids During the Prediabetic Period in a Pig Model With Impaired Incretin Function and Reduced β-Cell Mass in another window
Includes: Supplementary data
Journal Articles

Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet

Melanie Becker, Katja Rabe, Corinna Lebherz, Julia Zugwurst, Burkhard Göke, Klaus G. Parhofer, Michael Lehrke, Uli C. Broedl
Journal: Diabetes
Diabetes 2010;59(11):2898–2903
https://doi.org/10.2337/db10-0362
Published: 09 August 2010
View article titled, Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet
Open the PDF for Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet in another window
Includes: Supplementary data
Journal Articles

Glucose Intolerance and Reduced Proliferation of Pancreatic β-Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function

Simone Renner, Christiane Fehlings, Nadja Herbach, Andreas Hofmann, Dagmar C. von Waldthausen, Barbara Kessler, Karin Ulrichs, Irina Chodnevskaja, Vasiliy Moskalenko, Werner Amselgruber, Burkhard Göke, Alexander Pfeifer, Rüdiger Wanke, Eckhard Wolf
Journal: Diabetes
Diabetes 2010;59(5):1228–1238
https://doi.org/10.2337/db09-0519
Published: 25 February 2010
View article titled, Glucose Intolerance and Reduced Proliferation of Pancreatic β-Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function
Open the PDF for Glucose Intolerance and Reduced Proliferation of Pancreatic β-Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function in another window
Includes: Supplementary data
Journal Articles

Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance

Maria M Byrne, Katja Gliem, Uwe Wank, Rudolf Arnold, Martin Katschinski, Kenneth S Polonsky, Burkhard Goke
Journal: Diabetes
Diabetes 1998;47(8):1259–1265
https://doi.org/10.2337/diab.47.8.1259
Published: 01 August 1998
View article titled, Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance
Open the PDF for Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance in another window
Journal Articles

Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide

Frank Kolligs, Hans-C Fehmann, Rüdiger Göke, Burkhard Göke
Journal: Diabetes
Diabetes 1995;44(1):16–19
https://doi.org/10.2337/diab.44.1.16
Published: 01 January 1995
View article titled, Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide
Open the PDF for Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide in another window